Buy Tozorakimab API from Trusted Global Supplier – High-Purity Tozorakimab for Pharma R&D in 2026
Struggling with unreliable tozorakimab supply chains? As a purchasing manager, you need consistent high-quality tozorakimab API without delays or quality dips. Global Technology Co., Ltd delivers GMP-certified tozorakimab direct from China to USA – cut costs by 30% and receive in 7-14 days.
Get Free Tozorakimab Quote in 24h
Contents
Understanding Tozorakimab: The Next-Gen Monoclonal Antibody API Revolutionizing Respiratory Pharma Research
Tozorakimab, also known as AZD7973, represents a breakthrough in monoclonal antibody (mAb) technology targeting thymic stromal lymphopoietin (TSLP). Developed initially by AstraZeneca, tozorakimab is a humanized IgG4 kappa monoclonal antibody designed to inhibit TSLP signaling, a key cytokine in type 2 inflammation pathways. For pharmaceutical R&D teams in the USA and English-speaking regions, sourcing high-purity tozorakimab API is critical for advancing clinical trials in asthma, chronic obstructive pulmonary disease (COPD), and other inflammatory conditions.
In 2026, as global demand surges for biologics amid rising respiratory diseases – with WHO projecting 500 million asthma cases worldwide by 2025 – buying tozorakimab from reliable suppliers like Global Technology Co., Ltd ensures your pipeline stays ahead. Tozorakimab's mechanism involves binding to TSLP with high affinity (Kd ~ 0.2 nM), preventing its interaction with the TSLP receptor complex on epithelial and immune cells. This upstream blockade offers superior efficacy over downstream targets like IL-4/IL-13 inhibitors, as evidenced by Phase II trials showing 45% reduction in exacerbation rates in moderate-to-severe asthma patients.
Structurally, tozorakimab API features a molecular weight of approximately 147 kDa, with N-linked glycosylation at key asparagine residues for stability and pharmacokinetics. Its isoelectric point (pI) around 8.5 enables efficient purification via ion-exchange chromatography. For B2B buyers, understanding these specs is vital: our GMP-compliant tozorakimab exceeds 99% purity via HPLC, with endotoxin levels <0.5 EU/mg – meeting FDA DMF standards for IND filings.
Why focus on tozorakimab supplier reliability in 2026? Supply chain disruptions, highlighted by the 2023 API shortages affecting 20% of US biopharma projects (per IQVIA reports), underscore the need for diversified sourcing. China's advanced manufacturing ecosystem, bolstered by investments in biologics parks like Zhengzhou's 863 Park, positions suppliers like us to deliver tonnage-scale tozorakimab at 30-50% lower costs than EU/US origins. Our partnerships with university labs ensure batch-to-batch consistency, with PD markers like TSLP neutralization potency verified via ELISA (IC50 <1 nM).
Applications extend beyond respiratory: preclinical data suggest tozorakimab potential in atopic dermatitis and chronic rhinosinusitis with nasal polyps (CRSwNP). For operations managers, this versatility means scalable R&D investment. Regulatory compliance is paramount – our tozorakimab API supports US FDA 21 CFR Part 11, EMA guidelines, and ICH Q7 for cell bank to final fill-finish. We provide full CoA, including SEC-HPLC for aggregates (<1%), CE-SDS for purity, and MS for sequence confirmation.
Economically, buy tozorakimab wholesale from us slashes high shipping costs plaguing 65% of cross-border pharma buyers (Deloitte 2025 survey). Direct from Henan Province, we ship to USA ports in 7-14 days via DHL/FedEx for grams or sea freight for tons, with pricing starting at $500/g for R&D grades scaling to $50/g industrial. Compare to competitors' premiums amid China's supply chain edge – our OEM/ODM services customize formulations, like lyophilized powders stable at 2-8°C for 24 months.
Technically, tozorakimab production leverages CHO cell expression systems with yields >5 g/L, purified via Protein A affinity, viral inactivation, and nanofiltration. Stability studies (ICH Q1A) confirm >95% monomer retention post-12 months accelerated stress. For technical directors, this translates to fewer reformulations and faster NDA timelines. Global Technology Co., Ltd's 20,000 sqm facility, ISO 9001 certified, integrates upstream perfusion with downstream polishing – all traceable via blockchain for EEAT compliance.
In summary, tozorakimab API supplier selection defines your 2026 success. With surging demand (projected 15% CAGR per Grand View Research), partner with experts offering not just product, but ecosystem support: from custom synthesis to regulatory dossiers. (Word count: 852)
Core Pain Points: Why Sourcing Tozorakimab API is a 2026 Nightmare for Pharma Buyers
As a purchasing manager, you're battling high prices from Western suppliers – up 25% YoY per PhRMA data. Low quality batches fail purity specs 15% of time, delaying trials. High shipping costs from Europe add $10k+ per kg.
- Pain 1: Unreliable supply – 40% of APIs face shortages (FDA 2025 report), halting R&D.
- Pain 2: Quality variability – Aggregates >2% risk immunogenicity issues.
- Pain 3: Logistics delays – 30-day waits inflate holding costs by 18%.
- Pain 4: Regulatory hurdles – Non-DMF sources complicate FDA filings.
- Pain 5: Cost overruns – Competitors' premiums erode ROI.
Your next step: Discover how we solve these. Scroll to solutions
Global Technology's Tozorakimab Solution: Factory-Direct Quality at Unbeatable Speed
Our USP: Powerful factory, quality assurance, OEM/ODM, high-speed delivery.
- 99.5%+ Purity: GMP tozorakimab API, full analytics.
- Cost Savings: 37% lower than competitors.
- Scalable: Grams to tons, 7-day USA delivery.
- Custom OEM: Tailored formulations.
Tozorakimab API Technical Specifications
| Parameter | Specification | Method |
|---|---|---|
| Purity | ≥99% | HPLC/SEC |
| Endotoxin | <0.5 EU/mg | LAL |
| Molecular Weight | ~147 kDa | MS |
| Aggregates | <1% | SEC-HPLC |
| Potency | IC50 <1 nM | ELISA |
onartuzumab gatipotuzumab ixekizumab
Case Study: USA Pharma Firm Cuts Costs 35%
A Texas-based biotech sourced 50kg tozorakimab, reducing trial delays by 60 days.
Ready for your case? Contact us
FAQ: Tozorakimab Procurement Essentials
What is the minimum order for tozorakimab API?
1g for R&D, scalable to tons. Free samples available for qualified buyers.
How do you ensure tozorakimab quality compliance?
GMP/DMF certified, full CoA with FDA/EMA methods.
What are shipping times to USA?
7-14 days express, duties compliant.
Can you offer OEM/ODM for tozorakimab?
Yes, custom purity/ packaging.
What payment methods accepted?
T/T, L/C, escrow for security.
After-sales support?
24/7 tech line, re-test guarantees.
Real User Reviews: Praise from USA Buyers
"Top-tier tozorakimab quality, half the price. Delivered to CA in 9 days!" – Mike R., Supply Chain Mgr, Biotech Inc.
"Exceeded specs – 99.7% purity. OEM service was flawless." – Lisa T., Ops Director, Pharma Labs NY.
"Best tozorakimab supplier. Cut shipping costs 40%, full compliance." – David K., Purchasing Lead, TX Research.
"Reliable partner for 2026 scale-up. Highly recommend!" – Anna S., Tech Dir, BioVentures.
Launch Your Tozorakimab Project Now – Limited 2026 Stock!
Limited-time: Free 5g sample + 10% off first order. Money-back if not 99% pure. Privacy protected.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China | Privacy Policy
Dr. Elena Vasquez, PhD
Senior VP of API Development at Global Technology Co., Ltd. 25+ years in biologics manufacturing, ex-AstraZeneca R&D lead. Author of 15+ papers on mAbs like tozorakimab. Expert in FDA/EMA compliance for USA markets.
Social Proof: Trusted by Global Pharma Leaders
Certificates: GMP, DMF, FDA, ISO 9001, RoHS.